A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can significantly improve—and in some cases even reverse—advanced liver disease. The findings come from the ESSENCE Phase III clinical trial,

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, according to the New England Journal of Medicine.